Thomas Reiberger Selected Research

Liver Diseases (Liver Disease)

10/2022	Gadoxetic acid-enhanced MRI-derived functional liver imaging score (FLIS) and spleen diameter predict outcomes in ACLD.
8/2022	Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis.
6/2022	Transplantation of hepatitis D virus patients: Lifelong hepatitis B immunoglobulins?
4/2022	HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease.
1/2022	The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis.
1/2022	Baveno VII - Renewing consensus in portal hypertension.
1/2022	Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis.
1/2022	Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD.
1/2022	Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies.
12/2021	Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Reiberger Research Topics

Disease

65	Fibrosis (Cirrhosis) 12/2022 - 01/2008
51	Portal Hypertension 10/2022 - 07/2011
50	Liver Diseases (Liver Disease) 10/2022 - 01/2015
27	Liver Cirrhosis (Hepatic Cirrhosis) 11/2022 - 06/2012
21	Hepatocellular Carcinoma (Hepatoma) 05/2022 - 04/2014
19	Hemorrhage 12/2022 - 11/2013
18	Infections 06/2022 - 07/2011
17	Inflammation (Inflammations) 06/2022 - 01/2008
16	Ascites 07/2022 - 01/2014
14	End Stage Liver Disease 10/2021 - 01/2017
10	Hepatitis C 10/2022 - 01/2013
9	Coinfection 06/2022 - 07/2010
8	Varicose Veins (Varicose Vein) 04/2022 - 11/2013
8	Neoplasms (Cancer) 01/2021 - 04/2014
7	Non-alcoholic Fatty Liver Disease 08/2022 - 03/2017
7	Disease Progression 06/2022 - 09/2019
6	Hepatic Encephalopathy 02/2021 - 01/2018
6	Chronic Hepatitis C 01/2021 - 01/2013
5	Acute-On-Chronic Liver Failure 01/2022 - 10/2017
4	COVID-19 12/2022 - 01/2021
4	Cholestasis 12/2022 - 02/2015
4	Anemia 12/2022 - 07/2011
4	Thrombosis (Thrombus) 01/2022 - 07/2018
4	Fatty Liver 01/2020 - 01/2018
4	Hypertension (High Blood Pressure) 09/2019 - 01/2017
3	Chronic Hepatitis B 06/2022 - 01/2012
3	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2022 - 12/2020
3	Sepsis (Septicemia) 05/2021 - 11/2017
3	Acquired Immunodeficiency Syndrome (AIDS) 11/2013 - 08/2012
2	Thrombocytopenia (Thrombopenia) 12/2022 - 07/2011
2	Liver Failure 12/2022 - 01/2020
2	Alcoholic Liver Diseases (Alcoholic Liver Disease) 08/2022 - 01/2021
2	Hepatitis B 06/2022 - 01/2013
2	Liver Neoplasms (Liver Cancer) 04/2022 - 12/2015
2	Viremia 12/2021 - 01/2020
2	Hepatorenal Syndrome 05/2021 - 11/2018
2	Critical Illness (Critically Ill) 01/2021 - 11/2017
2	Cicatrix (Scar) 01/2020 - 01/2017

Drug/Important Bio-Agent (IBA)

18	4-(3-chlorophenylsulfanyl)piperidineIBA 02/2022 - 07/2011
14	InterferonsIBA 04/2022 - 01/2008
13	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2014
13	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2008
11	RNA (Ribonucleic Acid)IBA 10/2022 - 01/2011
10	von Willebrand FactorIBA 08/2022 - 10/2012
10	AlbuminsIBA 04/2022 - 01/2018
9	C-Reactive ProteinIBA 01/2022 - 01/2018
8	Ribavirin (Virazole)FDA LinkGeneric 03/2018 - 07/2010
7	Proteins (Proteins, Gene)FDA Link 08/2022 - 01/2008
7	Alanine Transaminase (SGPT)IBA 01/2019 - 01/2008
6	Propranolol (Inderal)FDA LinkGeneric 07/2022 - 11/2013
5	gadolinium ethoxybenzyl DTPA FDA Link 10/2022 - 01/2017
5	Carvedilol (Coreg)FDA LinkGeneric 07/2022 - 11/2013
5	AntigensIBA 12/2021 - 10/2012
5	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 11/2009
4	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2022 - 08/2015
4	Transaminases (Aminotransferases)IBA 01/2022 - 02/2015
4	Interleukin-6 (Interleukin 6)IBA 12/2021 - 05/2013
4	CreatinineIBA 01/2021 - 11/2015
4	SodiumIBA 01/2021 - 09/2015
4	LipidsIBA 09/2019 - 03/2017
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2019 - 01/2015
3	BilirubinIBA 12/2022 - 12/2019
3	CollagenIBA 11/2022 - 04/2014
3	AnticoagulantsIBA 05/2022 - 07/2018
3	Bevacizumab (Avastin)FDA Link 01/2022 - 12/2015
3	ReninIBA 12/2021 - 01/2017
3	Bile Acids and Salts (Bile Acids)IBA 11/2021 - 01/2017
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2021 - 01/2018
3	Messenger RNA (mRNA)IBA 11/2020 - 11/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020 - 05/2016
3	Polytetrafluoroethylene (Teflon)FDA Link 01/2018 - 12/2017
3	InterleukinsIBA 03/2015 - 07/2011
2	TransferasesIBA 12/2022 - 01/2019
2	Complement C3 (C3 Complement)IBA 11/2022 - 01/2014
2	lipopolysaccharide-binding proteinIBA 01/2022 - 01/2017
2	bulevirtideIBA 01/2022 - 01/2022
2	ProcalcitoninIBA 01/2022 - 01/2021
2	Thrombin FDA Link 01/2022 - 01/2022
2	fibrin fragment D (D-dimer)IBA 01/2022 - 12/2021
2	atezolizumabIBA 01/2022 - 01/2022
2	AldosteroneIBA 12/2021 - 10/2021
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2021 - 01/2012
2	Hormones (Hormone)IBA 10/2021 - 02/2019
2	Hydroxyproline (4 Hydroxyproline)IBA 01/2021 - 12/2020
2	Immune Checkpoint InhibitorsIBA 01/2021 - 05/2015
2	TerlipressinIBA 01/2021 - 11/2018
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 11/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2021
2	riociguatIBA 12/2020 - 01/2018
2	Vitamin A (Retinol)FDA LinkGeneric 12/2020 - 01/2020
2	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 12/2020 - 01/2020

Therapy/Procedure

37	Therapeutics 05/2022 - 01/2008
19	Liver Transplantation 06/2022 - 03/2017
12	Transjugular Intrahepatic Portasystemic Shunt 12/2022 - 09/2017
10	Surgical Portasystemic Shunt (Portosystemic Shunt) 12/2022 - 12/2017
9	Ligation 01/2022 - 11/2013
4	Stents 08/2022 - 12/2017
4	Immunotherapy 01/2022 - 05/2015
3	Transplantation 06/2022 - 10/2012
2	Contraindications 12/2022 - 05/2014